Episode Details
Back to Episodes
Episode 507: ASCO 2026 - TALAPRO-3
Published 4 months, 3 weeks ago
Description
Neeraj Aggarwal joins the show to discuss the phase 3 TALAPRO-3 trial of talazoparib and enzlautamide in metastatic hormone-sensitive prostate cancer, focusing on trial design, efficacy, safety, and genetic subsets.